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ABSTRACT 
 
Background and Setting: Radiation fibrosis  
syndrome/ Radiation-induced fibrosis 
(RFS/RIF) occurs as a consequence of the 
progressive fibrotic sclerosis that occur 
following the radiation (various types) 
therapy for cancer; and the term has been 
used to describe its innumerable clinical 
manifestations. Fibrosis is the primary 
complication of radiation and is said to 
influence the quality of life of a cancer 
survivor. For treatment of the Radiation 
Induced Fibrosis, understanding the 
pathogenesis of RIF is essential. 
 
RIF is a consequence of a defective response 
to the wound healing. The response is the 
after-effect of the inflammatory changes 
that set in, due to the direct DNA damage 
and the free radicals generated from the 
ionising radiation. Inflammation, resulting 
in an increased TGF-β along with a host of 
other cytokines and growth factors, leads to 
fibrosis, that is manifested by increased 
collagen deposition, poor vascularity and 
scarring. The drugs for RIF have been 
directed against these molecules and their 
associated signaling pathways. 
 
Conclusion: The main purpose of this 
article is to provide reasoning and 
stronger know-how of issues related to RIF 
and to suggest methods to prevent the 
radiation morbidity. 
 
INTRODUCTION 
 
 
 
 
 
The radiation therapy is used in treatment 
of head and neck cancers especially the 
squamous cell carcinoma: either alone or in 
combination with surgery and chemotherapy. 
[1] The immediate effect (usually 4–12 
months), of irradiation on normal tissues is 
influenced by the radio-sensitivity of the 
individual patients. For, e.g., the mutated 
ATM (ataxia telangiectasia mutated) in the 
patients, diminishes the ability of cells to 
repair the radiation-induced DNA damage; 
thereby indicating a high radio-sensitivity. 
On the other hand, there is a variation in 
severity of the late effects of radiation 
that depends on the radiation dose, volume 
of the site treated, and the size of the 
lesion. [2] Radio-sensitizers and radio-
protectants are introduced to limit the 
radiation exposure to noncancerous cells, 
thereby reducing its adverse effects. [3] 
The recurrent lesions, when viewed on the 
radiograph, may appear very perplexing and 
may sometimes be mistaken for a recurrent or 
a residual tumour. These lesions may lead to 
a condition called as the Radiation fibrosis 
syndrome (RFS) that may be seen clinically, 
years after the treatment.[2] Radiation-
induced fibrosis (RIF), may commonly occur 
in the skin and subcutaneous tissues, 
gastrointestinal tract, lungs, and 
genitourinary tracts, as well as other 
organs that are in the path of the 
treatment. Patient-related factors, like 
pre-existing connective tissue 
diseases, like for, e.g., Marfan syndrome, 
systemic scleroderma and (SLE) systemic 
lupus erythematosus are more likely to 
develop severe RIF. 
 
Epigenetic modifications to DNA and 
histones have been associated with RIF as 
noticed by the inhibition of cutaneous 
radiation syndrome by inhibitors of 
histone deacetylase. These types of DNA 
alterations are long term, and as such, 
they produce fibrosis in response to 
radiation injury that remains even after 
the initial insult is no longer present. 
[2] 
 
The patient and the clinicians do not 
formulate the steps required to encounter 
the late effects of head and neck cancer 
(HNC) therapy, as the stint during the 
active treatment is tough, exhausting and 
time-consuming; for both the patient and 
provider. The patient, therefore, looks to 
relax and heal, on completion of the 
therapy. The immediate post-treatment 
period is when the rigorous rehabilitation 
needs to be implemented, to improve the 
post-therapy functioning of the patient. 
It is, therefore, the duty of the 
clinician to warn the patient of the 
impending dangers; thereby helping in 
improving the life and reducing the 
symptoms of the long-term survivors of 
HNC. There is a lack of appropriate 
therapies that are available; to counter 
the late effects of HNC therapy, which 
doubles up the attempts in optimising the 
long-term supportive care outcomes. [4] 
 
Radiation-induced damage can include “myelo-
radiculo-plexo-neuro-myopathy” causing 
muscle weakness and dysfunction and also 
contributing to the neuromuscular injury. 
[2] The general manifestations of RIF 
include skin induration, limited joint 
mobility, muscle shortening and atrophy, 
mucosal fibrosis, lymphedema, ulceration, 
fistula and pain. Other local  
manifestations include xerostomia, trismus, 
osteoradionecrosis, decreased vocal quality, 
aspiration and dysphagia in patients with 
head and neck malignancies; brachial and 
cervical plexopathy, hypoxia, interstitial 
fibrosis, dyspnea with breast or lung 
malignancy; and the manifestations of 
increased urinary frequency, urinary 
urgency, dyspareunia, diarrhoea, loss of 
reproductive function in patients with 
abdominopelvic malignancy. [5] 
 
Pathogenesis of RIF 
Animal model studies on cancer therapy-
related tissue toxicities have shown that 
the pathways during the normal healing 
process and in the case of the RIF are the 
same; wherein the TGF β superfamily and a 
multitude of pro-inflammatory cytokines are 
involved. The only difference between the 
two is that, in fibrosis, these signalling 
pathways escapes the standard cellular 
regulation. This result in a permanent 
injury state and the processes involved in 
normal healing are upstaged. [6] Anaemia, 
thrombocytopenia, and neutropenia are among 
the most common complications linked to 
radiation and chemotherapy; and the cancer 
patients may also be at a high risk for a 
varied sequence of non-hematological 
toxicities. 
 
The molecular mechanisms following the 
cancer therapy have mostly been obtained 
from animal models. It has been stated 
that the immediate insult following 
chemotherapy and radiation, is a cellular 
response involving a specific cell type 
that occurs in stages: 
 
• The inflammatory phase, in which the 
inflammatory cells are engaged; release 
cytokines that draw the immune cells and 
the fibroblasts to the site of injury. 
 
• The proliferative phase, where the 
proliferating fibroblasts, migrate to the 
site of injury to form a scaffold on a 
temporary fibronectin matrix to deposit 
collagen type III to form a new barrier. 
[4] 
 
• Where the proliferated fibroblasts, 
remodel themselves, with the help of both 
matrix building proteins and the secreted 
proteases, from local fibroblasts, to build 
up a new ECM (extracellular matrix), by the 
converting the flexible collagen type III 
into the more permanent collagen type I. 
These fibroblasts (myofibroblasts) are said 
to be heterogenous with the recruited 
fibroblast having various forms each 
assigned a specialized function; and vary in 
rates of proliferation, in response to 
inflammatory signals and ECM production. 
Fibro-nectin, collagen, and proteoglycans, 
resulting in the increased thickening and 
stiffness of the tissue. [5] 
 
• The TGF-β also, promotes a reduced 
matrix metalloproteinase (MMP) activity 
(especially MMP-9 and MMP-2) and an 
additional activity of tissue inhibitors 
of metalloproteinases (TIMPs), adding to 
the already disproportionate ECM 
deposition. 
 
• Although  the  myofibroblasts  stimulate  
angiogenesis and endothelial cell 
proliferation by secretion of basic 
fibroblast growth factor (βFGF), the 
excess collagen reduces the vascularity 
over time. Therefore the fibrotic areas 
would be more susceptible to gradual 
ischemia and physical trauma, leading to 
the loss of function, reduced fibroblasts 
and necrosis and also the tissue atrophy. 
But surprisingly, no relation has been 
found between the severity of early 
fibrotic lesions and the development of 
late effects of RIF. [5]  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 1: Oral mucositis. Picture Courtesy: Osama 
Muhammad Maria, et al. Front Oncol. 2017; 7: 89. 
Republished with the permission of Dr Patrick Stiff, 
Loyola University Medical Center, Maywood, IL, USA. 
 
Diagnosis of RIF 
 
Diagnosis of RIF is likewise is dependent 
on the site affected. In the skin or 
subcutaneous tissue, for instance, it may 
be done by palpation; in the muscle, by 
Young's modulus measurements (tensile or 
stiffness), using ultrasound to provide 
more quantitative measurements. As it 
stands, there remains no uniform 
consensus, with respect to objectively 
quantifying the degree of fibrosis, and 
there is an inconsistency in the grading 
scales like the version 4.0 of the Common 
Terminology Criteria for Adverse Events 
and the Radiation Therapy Oncology Group 
(RTOG), and the latter does not 
specifically address the RIF and the 
overall radiation toxicity. [4] 
 
How can this action be suppressed? 
 
Animal models have shown that the epithelium 
that is engineered to suppress Smad3 has a 
reduced fibrotic response and that the Smad3 
null animals demonstrate an accelerated 
wound repair characterised by 
enhanced re-epithelialization with a 
reduced inflammatory response. A meta-
analysis of other studies has failed to 
show a relationship between the three SNPs 
commonly associated with TGFβ1 and the 
hazard of late radiation-induced normal 
tissue damage. 
 
TNF- α has been found to be a negative 
regulator of TGF-β and therefore has anti-
fibrotic activity. Also, the auto grafted 
TNF-α applied directly to injured skin 
minimises the deposition of collagen. 
 
Oral mucosal lesions comprise of deep, 
diffuse, and extremely painful ulcers that 
involve mobile mucosa. (Figure 1) This 
occurs when the radiation is subjected daily 
for five days/ week, in small, fractionated 
doses of 2Gy, amounting to a cumulative dose 
of 60–70Gy. On the other hand, the 
chemotherapy is given either every three 
weeks or weekly during the radiation period 
(days 0, 21, and 42), but in smaller doses. 
The mucositis occurring as a consequence is 
routine. At the end of the first week of 
treatment (where a cumulative radiation dose 
of 10Gy is subjected) the mucosa becomes 
erythematous are may sometimes be 
accompanied by a degree of pain equivalent 
to a bad food burn. By subjection to a 
cumulative dose of 30Gy, ulceration 
develops. As compared to the aphthous 
ulcers, these are more extensive and 
profound and painful which may require 
analgesics which may prove ineffective. 
Subepithelially, these ulcers undergo 
fibrosis which may result in trismus, 
characterised by a restriction of mouth 
opening often referred to as "lock jaw."  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2: HE-Stain. In previously not irradiated 
tissue (a; scale) sebaceous glands, eccrine sweat 
glands, hair follicles as well as collagen and 
elastic fibres can be found in the epidermis. In 
irradiated tissue (b; scale bar = 250 μm) an 
epidermal atrophy with the ratification of sweat and 
sebaceous glands could be found. No intact hair 
follicles could be identified. A detailed 
enlargement (c; scale bar = 50 μm) shows 
hypereosinophilic superficial epidermal layers as 
well as inflammatory cells in the dermis. Not shown 
in this enlargement are hyperpigmentations in the 
epidermis and numerous melanophages. Pic Courtesy: 
Steffen Koerdt, et al. Radiat Oncol. 2015; 10: 202. 
 
The initial phase shows oxidative stress 
and stimulation of the innate immune 
response, mainly in the endothelium and 
stroma after the radiation exposure. This 
leads to a canonical pathway causing a 
cytokine cascade resulting in a fibro-
nectin breakdown, and proliferation of  
pro-inflammatory cytokine signaling cascades 
like the TGFβ and TNF-α pathway. Finally, 
ulceration occurs (Figure 4). Secondary 
bacterial infection and an exposed surface 
epithelium cause the stimulation of the 
macrophages to produce additional cytokines. 
The mucosa makes all attempts to prevent 
this invasion by causing an altered 
fibrosis. This results in trismus causing 
difficulty to the patient. The salivary 
function is disturbed due to parenchymal 
replacement with fibrous tissue and 
development of oesophagal strictures. Of 
these, the mucositis is acute, whereas the 
fibrosis-related changes are more chronic 
and may cause complications in the otherwise 
healed cancer patient. [7]The lining of the 
small blood vessels comprising of 
endothelial cells is destroyed, resulting in 
subsequent fibrosis, following the ischemia, 
edema, inflammation and finally a delayed 
fibrosis. (Figure 2) All tissues that 
surround the blood vessels of the head and 
neck may be affected, due to the 
interstitial edema, or the edema that 
develops in the surrounding soft tissues 
during the radiation therapy; or the ensuing 
months after radiation therapy. This is seen 
as a thickening of skin (Figure 3) and 
platysma muscle, edema in deep neck spaces 
such as the carotid sheath and reticulation 
of subcutaneous and deep fat tissues, on MRI 
images. 
 
 
The salivary glands and thyroid tissues 
also become edematous and appear 
heterogeneous, with the images on MRI 
showing altered signal intensity (low on 
T1, high on T2). The degree of enhancement 
differs, but is typically diverse, in the 
early post-treatment stages. Xerostomia 
occurs as a follow-up to parotid atrophy, 
and thyroid atrophy may produce 
hypothyroidism. 
 
Complications of Radiation Therapy 
 
Any growing mass, bone or chondroid 
destruction or lymphadenopathy, must be 
viewed with suspicion for recurrence. A 
neoplasm is considered radiation- induced 
if it has an altered histopathology; 
different from that of an original 
neoplasm; developing within an irradiated 
field; more than 5 years after treatment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3: Radiation-induced damage in the cervical 
region (radiation dose of 64 Gy). Picture Courtesy: 
Steffen Koerdt, et al. Radiat Oncol. 2015; 10: 202. 
 
Mucosa and Submucosa 
 
During the early days of treatment, there 
is commonly a mucosal irritation [8] and 
edema, which may result in pain and 
dysphagia and that, may limit the oral 
intake, and in extreme cases, it may also 
cause an airway obstruction. Necrosis of 
the pharynx and larynx is maximum during 
the first 12 months after treatment, or 
sometimes more than 10 years after 
radiation therapy. Mucosal ulceration, if 
deep, should alert the patient and 
clinician. The end stage of all these 
steps is the fibrosis and atrophy of the 
affected tissue and a reduction in the 
capacity of all tissues of the neck. 
Muscles may undergo fibrosis; mainly the 
pterygoid and temporomandibular joint. MRI 
images reveal a loss of muscle volume with 
hyperintense T2 signal and enhancement 
with a linear boundary that would indicate 
a defined radiation field. This finding 
indicates a differentiation in the 
radiation effect arising from the  
denervation. Muscle T2 signal 
hyperintensity is said to be maximum at  
approximately 12–18 months after 
radiation, whereas on the other hand, the 
accompanying muscle atrophy tends to slow 
at approximately 18 months. 
 
Bone and Cartilage 
Osteoradionecrosis (ORN) of the mandible, 
hyoid, skull base, or upper cervical spine 
occurs when the cell injury and the 
radiation fibrosis reduces the ability of 
tissues to adjust to normal turnover, 
therefore resulting in tissue breakdown. 
[1]The exposed irradiated bone tissue that 
does not heal over a period of 3 months; 
without a residual or recurrent tumor; (Marx 
gives a similar definition but with a 
healing period of 6 months) results in ORN. 
[3] Osteoradionecrosis (ORN) occurs 
predominantly in the first 6–12 months after 
radiation therapy; but may persist  
years after therapy. [1]Clinical 
manifestations of ORN: are exposed 
necrotic bone, ulceration, sequestra, 
purulent discharge, pain, paraesthesia, 
swelling, trismus, cutaneous fistula and 
pathologic fractures. ORN is more 
frequently observed in the mandible than 
the maxilla; due to its reduced 
vascularity and cortical nature of the 
bone and that it receives more irradiation 
than the latter. ORN mainly occurs 4 
months to 2 years after completion of 
radiation therapy. [3] 
 
To prevent ORN, the extraction should be 
done at least 21 days before the imitation 
of the radiation therapy to enable the 
initial healing process and also to enable 
the recently formed tissues to better 
withstand irradiation. Otherwise, if 
required post radiation, the extraction 
should be done within 4 months of therapy 
completion; beyond which the ORN risk 
increases. Once the safe period is over, 
alternatives, such as restoration or root 
canal treatment, are preferred. Marx's 
theory states that the HBO therapy should be 
used in case the teeth need to be extracted 
outside these periods. [3]The ORN on CT is 
seen as cortical disruptions and the loss of 
trabeculations. The development of new 
heterogeneous signal within the marrow of an 
irradiated area (intermediate or low T1 
signal, intermediate or high T2 signal) on 
an MRI should be attended to. It is 
extremely  
difficult to differentiate an 
osteoradionecrosis either with or without 
osteomyelitis from a recurrent tumor, but 
frank bone destruction without a soft-
tissue mass is most likely an ORN. 
 
• An imbalance between the normal 
homoeostasis of cell repair and cell 
death, collagen synthesis and collagen 
breakdown could be responsible for this 
phenomenon. 
• A second theory suggests that the 
suppression of osteoclasts by radiation 
directly affects bone turnover. This 
alteration is thought to occur earlier 
than vascular damage. 
 
• Also, a fibro-atrophic theory proposes 
that it is the reduced ability of 
fibroblasts to produce collagen that 
renders tissues weak and fragile 
 
Intense enhancement of the adjacent 
edematous muscles may be seen, which may 
be mistaken for a recurrent tumour if 
osseous changes are not visible in CT. The 
presence of a bulky soft-tissue mass 
together with bone destruction would 
indicate tumour recurrence, in which case 
a biopsy is mandatory. 
 
Nervous System 
 
When cancer of the skull base or 
nasopharyngeal carcinomas has been treated 
by radiation therapy, the temporal lobe 
necrosis is a complication; occurring months 
or < 5 years after treatment. The other 
complications may be a vagal neuropathy and 
hypoglossal palsy that can occur 2–10 years 
after radiation which may be caused by the 
entrapment of the nerve by fibrosis. Early 
months after treatment (1-2 years) may show 
an acute spinal cord injury which is usually 
reversible, whereas an enlargement indicates 
a delayed radiation myelopathy, which is 
uncommon. It manifests as a T2 hyper 
intensity, and enhancement. Radiation-
induced brachial plexopathy, as a recurrence 
of squamous cell carcinoma, is uncommon, and 
peaks at about 2–4 years after treatment 
especially of the breast carcinoma—the 
reason being that the nodal groups 
associated with head and neck tumors are 
separated and protected from the 
supraclavicular plexus by the anterior 
scalene muscle. Brachial plexus tumor 
manifests as pain, rather than numbness and 
weakness. 
 
Sarcomas occur approximately 10 years 
after radiation. The squamous cell 
carcinomas of the external auditory canal 
and the less common cerebral neoplasms are 
observed 10–15 years after the skull base 
radiation therapy. [1] 
 
Loss of function due to lymphedema and 
fibrosis 
 
Lymphedema is a consequence of an 
accumulation of fluid and proteins in the 
soft tissues, proximal to and surrounding 
the damaged lymphatic vessels. The damage 
could be a surgical error or following 
radiation-induced sclerosis. Lymphedema may 
cause the damage of soft tissues and may 
worsen a post-radiation swelling. In the 
later stages, the lymphedematous tissue 
becomes fibrotic, with a subsequent loss of 
tissue flexibility and function. Thus, 
lymphedema may be followed by fibrosis, and 
patients may suffer from both concurrently. 
The lymphedema may be internal (involving 
structures such as the pharynx and larynx) 
or maybe external (involving structures such 
as the neck, face and the sub-mental region. 
Lymphedema and fibrosis are common 
complications of patients treated for HNC 
notwithstanding the treatment modality and 
maybe associated with significant symptoms 
and function deficits. 
 
Dysphagia 
 
In patients treated with surgery, removal 
of vital structures would result in 
dysphagia and the patient would require a 
feeding tube later. The causes for 
dysphagia were proposed to be: a 
consequence of radiation-induced fibrosis 
or a chronic lymphedema leading to 
fibrosis. Persistent use of feeding tube 
was suggested as another reason for the 
dysphagia, following which there was a 
disuse atrophy of the musculature that 
aggravated the underlying physiologic 
change leading to the disturbance in 
function. There have been attempts to 
reduce the occurrence of long-term 
dysphagia, by minimising the radiation to 
structures, vital for swallowing; and the 
use of aggressive swallowing therapy 
during and after treatment. 
 
Earlier, the swallowing therapies were  
initiated only after swallowing 
difficulties arose; but this logic has 
found no takers. Anyways, it is important 
for preventive measures to be implemented  
for optimal long-term swallowing 
functions. 
 
The swallowing dysfunction has been 
reported to be bi-modal, with most 
patients experiencing an acute reduction 
in their swallowing function right after 
surgery and/or radiation therapy. So if  
swallowing therapy is implemented 
immediately, it would result in a 
substantial improvement in the swallowing, 
for most patients. Chronic inflammation and 
late tissue damage are unfortunate 
consequences of the cancer treatment– 
induced fibrosis and lymphedema. As late 
soft tissue damage manifests, patients may 
experience a slow decline in their 
swallowing functions. 
 
Strictures may follow either surgery or 
radiation, but not much information is 
available from the modulated radiation dose, 
volume, and target by IMRT (Intensity 
modulated therapy). Mucositis precedes 
stricture formation, and the simultaneous 
use of chemotherapy increases the incidence 
of stricture formation. Strictures have been 
successfully treated with dilation therapy 
regardless of the cause. The patient’s diet 
intake may suffer and more so if he has a 
history of smoking. The occurrence of the 
strictures as a late feature of radiation 
has made the clinician more cautious in 
treating the HNC. The patients are referred 
to a speech and language pathologists to be 
educated about consuming food orally and to 
reduce the dependence on the feeding tubes 
as soon as possible. The health care 
providers also monitor the swallowing 
function as part of routine follow-up. 
 
Trismus 
 
Both methods of treatment: surgery and 
radiation; damage vital structures that 
cause jaw movement, namely the tempero-
mandibular joint and muscles of 
mastication. Wherever there is tissue 
damage, it results in an uninhibited 
proliferation of fibroblasts leading to 
stricture formation and fibrosis. Trismus, 
as a consequence of the fibrosis, reduces 
the inter-incisal distance to >35 
millimetres in dentulous patients and >40 
millimetres in edentulous patients. The 
occurrence of this probability has been 
reported to be approximately 45%, and the 
prevalence was found much more reduced 
with IMRT than the conventional 
radiotherapy. Chemoradiotherapy either 
together with or postoperatively, with the 
above-mentioned treatment methods, further 
worsens the prevalence of trismus. 
Chewing, swallowing and speaking are 
affected as a consequence of trismus. 
Maintaining the oral health of these 
patients is also affected. Oral intubation 
is affected in those cases where it is 
being used. 
 
Forestalling this complication, the 
patients should be subjected to jaw-
stretching exercises to maintain health. 
Stretching devices should be used in cases 
where such complications develop. Postural 
abnormalities 
Postural abnormalities may also develop as 
an HNC. They may include the central 
collapse of the anterior chest, loss of 
normal lordosis in the lower back, 
kyphosis, and internal rotation of the 
humerus and protrusion of the head in a 
forward direction. The extent of this 
complication has not been reported. There 
are some processes that may contribute to 
postural abnormalities: 
 
• Primarily, the radiation and dissection 
in the neck may result in the soft tissue 
damage followed by fibrosis and 
contracture. 
 
• Secondly, the atrophy and the 
neurologic damage following radiation 
and/or surgery cause denervation and 
associated weakness; which may be apparent 
after prolonged activity. 
 
• Finally, alignment of the spine is 
affected due to severe deconditioning and 
muscle weakness. 
 
This may result in aspirational  
complications; musculoskeletal pain 
reduced pulmonary function as a result of 
the compression of the chest wall. 
 
Vascular Complications 
 
In 1983, Marx presented the 3-H concept: 
hypovascular, hypocellular and hypoxic 
environment (hence the name 3-H). [3] HNC 
therapies may cause vascular complications 
such as the stroke and the carotid artery 
rupture. Whenever the recurrence is seen 
close to the vascular structures, there is 
the likelihood for a carotid rupture but a 
possibility of it occurring, following 
chemotherapy would be as a pharyngo-
cutaneous fistula or non-malignant 
ulceration of the lateral wall of the 
hypopharynx. Whatever be the cause, since 
the mortality rate is high, prompt 
treatment needs to be advocated either by 
a surgical or endovascular approach. 
Radiation therapy may also cause 
pathologies in the medium and large 
arteries, such as increased intimal 
thickening that may further lead to 
ischemic attacks and strokes. This has 
been confirmed by a meta-analytic study, 
and its incidence will only increase as 
the prognosis following cancer therapy, 
improves. Currently, the screening for 
asymptomatic carotid artery stenosis is 
not advisable. Not much care is being 
taken for the anticipation of vascular 
complications, and therefore it would be 
advisable to monitor such patients who 
have a risk for cerebrovascular disease. 
[2] 
 
It can, therefore, be concluded that once a 
patient develops cancer, whatever be the 
treatment modality followed, he must be 
under observation throughout his entire 
life. Interventional therapies that are more 
evidence-based should be applied. Or at 
least, the patients should be educated 
regarding these complications, so as to 
decrease the stress and the anxiety of the 
patient. Also, researches need to be 
conducted so as to understand the late 
effects of radiation, better. [5] 
 
The prevalence of the RIFP has reduced from 
66% RIBP with 60 Gy in 5 Gy fractions to > 
1% with 50 Gy in 2 Gy fractions from the 
1960s to the present. [5] 
 
Treatment for RIFP 
 
Numerous therapies [9] have been proposed 
for RIFS, but none of them have shown 
positive results. The treatment includes  
analgesics, drugs targeting the 
antioxidant pathways, [10], etc.; and the 
measures to improve the everyday life of 
the patients are underway. [11] 
 
CONCLUSION 
 
The extent of the radiation field, the 
effect of the underlying tissues to the 
radiation effects and the resistance of the 
patient to radiation, determine the 
morbidity of the patient due to RFS. The 
patient's age, medical conditions, and other 
damaging disorders; the degenerative spine 
disease; cancer status; exposure to  
cardiotoxic, neurotoxic and other 
chemotherapies, influence the overall 
health of the patient; the type and 
duration of radiation therapy is also 
significant. The patients would not enjoy 
the benefits of an elaborate radiation  
FIGURE 4: Differential Diagnosis of Oral Mucositis. 
Picture Courtesy- Osama Muhammad Maria, et.al. Front 
Oncol. 2017; 7: 89. Republished with the permission 
of Dr. Patrick Stiff, Loyola University Medical 
Center, Maywood, IL, USA. (A) Local, denture-related 
lesion, (B) aphthous ulcer, (C) oral mucositis, and 
(D) oral mucositis (E) Oral Thrush 
 
therapy, due to a decreased tolerance to 
the therapies employed. 
 
Therefore interventional therapies are 
mandatory to prevent or treat fibrosis that 
occurs as sequelae to regimen-related 
toxicities. Just a clinical examination or 
cross-sectional imaging would be 
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